BlueROCKER®

The Foot Drop Orthosis BlueROCKER® 2 ½ has the same dynamic functions and stability as a BlueROCKER® 2.0 with the exception that the 2 ½ has a lower heel height, 7 mm, to adapt to modern shoes. The toe lift is also slightly lower, which results in more space in the toe box. Since the start in 1997 the Allard AFO has been the market leader with its unique functions and dynamic properties.
BlueROCKER® 2 ½ has all MikroFIX pre-applied to simply fitment of the padding. The strap solution is the same as on 2.0, made from a durable and strong material. The straps can be applied for either inside or outside closure on the orthosis. The foot plate on BlueROCKER® 2 ½ gives more space in the toe box. It is always important to adapt any Allard AFO to the heel height of the shoe. Read more about this in the Allard AFO Professional Instructions.

Recommended Range Of Application

BlueROCKER® is designed to manage footdrop in conditions such as Stroke, Multiple Sclerosis, Post Polio Syndrome, Muscular Dystrophy, Spinal Cord Injuries, Traumatic Brain Injuries, Guillian-Barre Syndrome, Charcot-Marie-Tooth, Myelomeningocele, Neuropathy or Cerebral Palsy. BlueROCKER® 2.0 is designed to support gait in conditions such as Posterior Tibialis Tendon Dysfunction (PTTD) and toe amputations. BlueROCKER® can also be used for partial foot amputations, most proximal level is Chopart.

Contraindications

BlueROCKER® 2 ½ should not be used when patients present with foot and/or leg ulcers, moderate to severe edema, moderate to severe foot deformities, severe proximal deficits (e.g. quadriceps spasticity, genu valgum or varum, genu recurvatum), severe spasticity.

Other

More about fitting and product selection can be found in the Allard AFO Professional Instruction.

Allard AFO STEP 1: Product Selection Play video
Allard AFO STEP 1: Product Selection
Allard AFO STEP 2: Size Selection Play video
Allard AFO STEP 2: Size Selection
Energy expenditure in stroke subjects walking with a carbon composite ankle foot orthosis

Author: Danielsson A, Stibrant Sunnerhagen K.

Source: J Rehabil Med 2004; 36: 165–168

One clinic's experience with carbon fiber orthoses in neuromuscular disease

Author: ANI MNATSAKANIAN BS et al.

Source: Muscle Nerve 000:000–000, 2016

Efficacy of prefabricated carbon-composite ankle foot orthoses for children with unilateral spastic cerebral palsy exhibiting a drop foot pattern.
Characterization of Defects in Polymaer Composites Used in Medical Devices by Means of X-ray Microtomography.

Author: Roberts Joffe, Fredrik Forsberg, Henrik Lycksam, Anders Sjögren

Source: ICTMS 2017 - 3rd International Conference on Tomography of Materials and Structures, 26-30 June 2017, Lund, Sweden

Multiplanar Stiffness of Commercial Carbon Composite Ankle-Foot Orthoses.
Comparison of five different methodologies for evaluating ankle–foot orthosis stiffness.
Carbon fiber ankle-foot orthoses in impaired population

Author: Megan M. Grunst, Robert C. Wiederien and Jason M.

Source: A systematic review Prosthetics and Orthotics International 2023

A Pilot Study to Assess the Immediate Effect of Dynamic Carbon Ground Reaction Ankle Foot Orthoses on Balance in Individuals with Charcot-Marie-Tooth in a Clinical Setting

Author: Burke K1,2, Cornell K1,3, Swartz Ellrodt A1,2, Grant N1,2, Paganoni S2,4,5 and Sadjadi R1,2*

Source: CMT study.2021

Preliminary research suggests the use of a kinetic return ankle foot orthosis is associated with small but significant shortterm increases in calf circumference, which in turn suggests [...]

Preliminary research suggests the use of a kinetic return ankle foot orthosis is associated with small but significant shortterm increases in calf circumference, which in turn suggests this type of device might reduce or protect against the risk of disuse muscle atrophy.

Author: Robert H. Meier, CO, BOCO; David C. Ruthsatz, CO, CPA; and Daniel, Cipriani, PT, PhD. 

Source: Lermagazine 2014

Related products